+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type, By Clinical Practice, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 5990571
Description Jump to:

Psychiatric Digital Biomarkers Market Trends

The global psychiatric digital biomarkers market size was valued at USD 631.29 million in 2024 and is projected to grow at a CAGR of 24.35% from 2025 to 2030. Increasing prevalence of mental health disorders, advancements in digital health technologies and growing demand for personalized medicine drive the psychiatric digital biomarkers market. Rising adoption of wearable devices and mobile health apps in mental healthcare contribute to the market growth. In April 2024, Sensors published a review on digital phenotyping's impact on neurological diseases, showing its potential to refine clinical trials and aid in early detection and monitoring through telemedicine and sensor technologies.

The global burden of mental health disorders is on the rise, with conditions such as depression, anxiety, bipolar disorder, and schizophrenia affecting millions of people worldwide. In 2023, Mental Health America, Inc found that 20.17% of youths aged 12-17 had encountered a major depressive episode, with 15% suffering severe impairment affecting daily activities. This increasing prevalence is driving the need for more effective tools to monitor and manage mental health conditions, leading to a growing interest in psychiatric digital biomarkers. In July 2022, Pervasive and Mobile Computing published findings showing significant differences in mood and digital markers (such as sleep and phone usage) between depressed and non-depressed individuals. It also confirmed that depression status could be accurately predicted using these digital biomarkers alone or combined with mood ratings.

Technological advancements in digital health technologies revolutionize the field of mental healthcare. Innovations such as artificial intelligence (AI), machine learning, and data analytics enable the development of sophisticated digital biomarkers that provide valuable insights into an individual’s mental health status. AI-powered algorithms analyze data from smartphone sensors to detect changes in behavior patterns that indicate early signs of a mental health crisis. In November 2023, an article in Frontiers in Psychiatry highlighted the potential of digital biomarkers in predicting and managing mood disorders, noting how smartphone data can monitor depression and treatment responses, wearable devices can track mood disorders more accurately in real-world settings, and AI advancements are opening up new diagnostic and therapeutic avenues.

There is a growing demand for personalized medicine in mental healthcare, as healthcare providers seek to tailor treatment plans to individual patients’ needs. Psychiatric digital biomarkers play a crucial role in enabling personalized interventions by providing objective data on patients’ symptoms and treatment responses. The increasing adoption of wearable devices and mobile health apps further fuels this trend, allowing for continuous monitoring of patients outside traditional clinical settings. In March 2022, DTU Health Tech researchers developed a method using voice analysis to identify bipolar disorder in individuals and monitor mood changes in patients, with personalized models providing the most accurate results.

Global Psychiatric Digital Biomarkers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global psychiatric digital biomarkers market report based on type, clinical practice, end-use, and region.

Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Wearable
  • Mobile based Applications
  • Sensors
  • Others

Clinical Practice Outlook (Revenue, USD Million, 2018 - 2030)

  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Other's (Safety, Pharmacodynamics/ Response, Susceptibility)

End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Healthcare companies
  • Healthcare Providers
  • Payers
  • Others (Patient, caregivers)

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type
1.2.2. Clinical Practice
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Psychiatric Digital Biomarkers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of mental health disorders,
3.2.1.2. Advancements in digital health technologies
3.2.1.3. Growing demand for personalized medicine
3.2.1.4. Rising adoption of wearable devices and mobile health apps
3.2.2. Market restraint analysis
3.2.2.1. Regulatory hurdles
3.3. Psychiatric Digital Biomarkers Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Psychiatric Digital Biomarkers Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Psychiatric Digital Biomarkers Market Type Movement Analysis
4.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Wearable
4.4.1. Wearable market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Mobile based Applications
4.5.1. Mobile based applications market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Sensors
4.6.1. Sensors market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Psychiatric Digital Biomarkers Market: Clinical Practice Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Psychiatric Digital Biomarkers Market Clinical Practice Movement Analysis
5.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by Clinical Practice, 2018 to 2030 (USD Million)
5.4. Diagnostic Psychiatric Digital Biomarkers
5.4.1. Diagnostic psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Monitoring Psychiatric Digital Biomarkers
5.5.1. Monitoring psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Predictive and Prognostic Psychiatric Digital Biomarkers
5.6.1. Predictive and prognostic psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Other’s (Safety, Pharmacodynamics/ Response, Susceptibility)
5.7.1. Other’s (safety, pharmacodynamics/ response, susceptibility) market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Psychiatric Digital Biomarkers Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Psychiatric Digital Biomarkers Market End Use Movement Analysis
6.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Healthcare Companies
6.4.1. Healthcare companies market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Healthcare Providers
6.5.1. Healthcare providers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Payers
6.6.1. Payers market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Others (Patient, Caregivers)
6.7.1. Others (patient, caregivers) market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Psychiatric Digital Biomarkers Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Koneksa
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Type benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Biogen Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Type benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Empatica Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Type benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Vivo Sense
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Type benchmarking
8.4.4.4. Strategic initiatives
8.4.5. IXICO plc
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Type benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Huma
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Type benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Sonde Health, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Type benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Clario
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Type benchmarking
8.4.8.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global psychiatric digital biomarkers market, by region, 2018 - 2030 (USD Million)
Table 3 Global psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 4 Global psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 5 Global psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 6 North America psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
Table 7 North America psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 8 North America psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 9 North America psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 11 U.S. psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 12 U.S. psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 14 Canada psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 15 Canada psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 17 Mexico psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 18 Mexico psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
Table 20 Europe psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 21 Europe psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 22 Europe psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 23 Germany psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 24 Germany psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 25 Germany psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 26 UK psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 27 UK psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 28 UK psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 29 France psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 30 France psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 31 France psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 33 Italy psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 34 Italy psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 36 Spain psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 37 Spain psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 38 Denmark psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 39 Denmark psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 40 Denmark psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 42 Sweden psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
Table 43 Sweden psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
Table 44 Norway psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 45 Norway psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
Table 46 Norway psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
Table 47 Asia Pacific psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific psychiatric digital biomarkers market, by clinical practice, 2018-2030, (USD Million
Table 50 Asia Pacific psychiatric digital biomarkers market, by end use, 2018-2030, (USD Million
Table 51 China psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 52 China psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 53 China psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 54 Japan psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 55 Japan psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 56 Japan psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 57 India psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 58 India psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 59 India psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 60 South Korea psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 61 South Korea psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 62 South Korea psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 63 Australia psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 64 Australia psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 65 Australia psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 67 Thailand psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 68 Thailand psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 71 Latin America psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 72 Latin America psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 74 Brazil psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 75 Brazil psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 77 Argentina psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 78 Argentina psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 79 MEA psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
Table 80 MEA psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 81 MEA psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 82 MEA psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 84 South Africa psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 85 South Africa psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 90 UAE psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 91 UAE psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 93 Kuwait psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 94 Kuwait psychiatric digital biomarkers market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Psychiatric digital biomarkers market: Market outlook
Fig. 5 Psychiatric digital biomarkers market: Segment outlook
Fig. 6 Psychiatric digital biomarkers market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Psychiatric digital biomarkers market driver impact
Fig. 9 Psychiatric digital biomarkers market restraint impact
Fig. 10 Psychiatric digital biomarkers market: Type outlook and key takeaways
Fig. 11 Psychiatric digital biomarkers market: Type movement analysis
Fig. 12 Wearable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Mobile based applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Sensors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Psychiatric digital biomarkers market: Clinical Practice outlook and key takeaways
Fig. 17 Psychiatric digital biomarkers market: Clinical Practice movement analysis
Fig. 18 Diagnostic psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Monitoring psychiatric digital biomarkers market estimates and forecast, 2018-2030, (USD Million
Fig. 20 Predictive and prognostic psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Other's (safety, pharmacodynamics/ response, susceptibility) market estimates and forecast, 2018-2030, (USD Million
Fig. 22 Psychiatric digital biomarkers market: End Use outlook and key takeaways
Fig. 23 Psychiatric digital biomarkers market: End Use movement analysis
Fig. 24 Healthcare companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Healthcare providers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Payers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Global psychiatric digital biomarkers market: Regional outlook and key takeaways
Fig. 29 Global psychiatric digital biomarkers market: Regional movement analysis
Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Koneksa
  • Biogen Inc.
  • Empatica Inc.
  • Vivo Sense
  • IXICO plc
  • Huma
  • Sonde Health, Inc.
  • Clario

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 631.29 million
Forecasted Market Value ( USD ) by 2030 $ 2290 million
Compound Annual Growth Rate24.3%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Digital Neuro Biomarkers Market Size, Share & Trend Analysis Report By Type, By Clinical Practice, By End Use, By Region, and Segment Forecasts, 2025 - 2030 - Product Image

Digital Neuro Biomarkers Market Size, Share & Trend Analysis Report By Type, By Clinical Practice, By End Use, By Region, and Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By Therapeutic Area, By End-use (Healthcare Companies), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By Therapeutic Area, By End-use (Healthcare Companies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Psychiatric Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Psychiatric Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Digital Biomarkers Market by Type, Therapeutic Area, End-Use - Global Forecast 2025-2030 - Product Image

Digital Biomarkers Market by Type, Therapeutic Area, End-Use - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Digital Biomarkers Market Analysis & Forecast to 2024-2034 - Product Image

Digital Biomarkers Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.